These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11454083)

  • 1. Clinical, histopathologic, and therapeutic aspects of subepidermal autoimmune bullous diseases with IgG on the floor of salt-split skin.
    Barnadas MA; González MJ; Planagumà M; Romaní J; Curell R; de Moragas JM; Alomar A
    Int J Dermatol; 2001 Apr; 40(4):268-72. PubMed ID: 11454083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
    Lazarova Z; Yancey KB
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
    Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
    Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoelectron microscopy in subepidermal autoimmune bullous diseases: a prospective study of IgG and C3 bound in vivo in 32 patients.
    Prost C; Labeille B; Chaussade V; Guillaume JC; Martin N; Dubertret L
    J Invest Dermatol; 1987 Dec; 89(6):567-73. PubMed ID: 3316411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear IgA bullous dermatosis of childhood with autoantibodies to a 230 kDa epidermal antigen.
    Kanitakis J; Mauduit G; Cozzani E; Badinand P; Faure M; Claudy A
    Pediatr Dermatol; 1994 Jun; 11(2):139-44. PubMed ID: 8041654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subepidermal bullous autoimmune disease associated with immune nephritis. Immunomorphologic studies.
    van Joost T; Muntendam J; Heule F; Stolz E; Vuzevski VD; ten Kate F
    J Am Acad Dermatol; 1986 Feb; 14(2 Pt 1):214-20. PubMed ID: 3512635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orf-induced immunobullous disease: A distinct autoimmune blistering disorder.
    White KP; Zedek DC; White WL; Simpson EL; Hester E; Morrison L; Lazarova Z; Liu D; Scagliarini A; Kurtz SE; White CR; Yancey KB; Blauvelt A
    J Am Acad Dermatol; 2008 Jan; 58(1):49-55. PubMed ID: 17919774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen.
    Chen KR; Shimizu S; Miyakawa S; Ishiko A; Shimizu H; Hashimoto T
    Br J Dermatol; 1996 Feb; 134(2):340-6. PubMed ID: 8746353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic methods in autoimmune subepidermal bullous diseases].
    Campos Domínguez M; Suárez Fernández R; Lázaro Ochaita P
    Actas Dermosifiliogr; 2006 Oct; 97(8):485-502. PubMed ID: 17067526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kd dermal antigen: the first case report from the United States.
    Mascaró JM; Zillikens D; Giudice GJ; Caux F; Fleming MG; Katz HM; Diaz LA
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 2):309-15. PubMed ID: 10640922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid?
    Salmhofer W; Kawahara Y; Soyer HP; Kerl H; Nishikawa T; Hashimoto T
    Br J Dermatol; 1997 Oct; 137(4):599-604. PubMed ID: 9390339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat direct immunofluorescence (DIF) test, using, 1 M NaCl treated skin, in the subepidermal autoimmune bullous diseases that contain IgG at the dermal epidermal junction.
    Barnadas MA; Gelpi C; Curell R; de Moragas JM; Alomar A
    J Cutan Pathol; 1999 Jan; 26(1):37-41. PubMed ID: 10189243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, demographic and immunopathological spectrum of subepidermal autoimmune bullous diseases at a tertiary center: A 1-year audit.
    De D; Khullar G; Handa S; Saikia UN; Radotra BD; Saikia B; Minz RW
    Indian J Dermatol Venereol Leprol; 2016; 82(3):358. PubMed ID: 27088957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
    Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
    Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case of subepidermal autoimmune bullous disease with psoriasis vulgaris reacting to both BP180 C-terminal domain and laminin gamma-1.
    Ishida S; Takahashi K; Kanaoka M; Okawa T; Tateishi C; Yasukochi A; Ishii N; Li X; Hashimoto T; Aihara M
    J Dermatol; 2015 Apr; 42(4):391-3. PubMed ID: 25683229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural immunocytochemistry of autoimmune bullous diseases.
    Karpouzis A; Vamvassakis E; Stavrianeas N; Koumantaki-Mathioudaki E; Karpouzi M; Vareltzides A
    Australas J Dermatol; 2002 May; 43(2):113-9. PubMed ID: 11982567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous tinea pedis with direct immunofluorescence positivity: when is a positive result not autoimmune bullous disease?
    Miller DD; Bhawan J
    Am J Dermatopathol; 2013 Jul; 35(5):587-94. PubMed ID: 22892469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lesional skin of linear IgA bullous dermatosis expresses growth-regulated peptide (GRO)-alpha.
    Tsunemi Y; Ihn H; Saeki H; Tamaki K
    J Dermatol; 2004 Jul; 31(7):546-51. PubMed ID: 15492419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.